MMR

Analyst: This Penny Stock Could Triple

PSTI stock hasn't touched $4.50 since 2014

Jul 31, 2018 at 2:15 PM
facebook X logo linkedin


B. Riley/FBR initiated coverage on Pluristem Therapeutics Inc. (NASDAQ:PSTI) with a "buy" rating and $4.50 price target -- a roughly 266% premium to last night's close. The analyst in coverage cited optimism surrounding the company's cell therapy treatments.

The bullish note has failed to spark a meaningful move higher in PSTI stock, though, which was last seen up 1% at $1.24. Longer term, the penny stock has been in a channel of lower highs and lows since topping out at an annual high of $2.12 last October -- though the $1.20 region has consistently emerged as a floor. What's more, the shares haven't traded near $4.50 since 2014.

psti stock daily chart july 31

Nevertheless, Pluristem Therapeutics has been a darling of analysts, with all four in coverage maintaining a "buy" or better rating. Plus, the average 12-month price target stands all the way up at $4. This puts the lagging stock at risk of downgrades and price-target cuts on continued weakness.

 

AI has exploded ever since ChatGPT set the world on fire near the end of 2022.

Numerous companies with connections to artificial intelligence have seen their stocks soar.

That includes Nvidia, the poster boy of AI.

Its stock has skyrocketed 716% since ChatGPT’s debut. But here’s the thing …

While everyone’s still counting their money from this first AI boom … Nvidia and countless others have moved on to the next stage.

That includes Big Tech, which is currently making a series of peculiar investments in a few strange companies. This has nothing to do with tech. At least on the surface …

Yet, these strange investments could be the early ripples of a massive wave …Without them, ChatGPT could stop operating … Amazon, Google, Microsoft and more could see profits drop drastically.

In fact, Elon Musk says these investments are critical when it comes to solving the number one problem facing AI.

Now, Silicon Valley legend Michael Robinson has identified two companies that could play a significant role in the solution.

Their stocks just may be the key to AI 2.0.

Find out more about these two companies today.
 (ad)